dhaiim

RARE 1D Long +18% Target

Long
NASDAQ:RARE   Ultragenyx Pharmaceutical Inc.
RARE stock analysis at 1D time frame, EMA20 and MACD(8,21,5) crossed up .
RSI (14) and RSI (7) > 50 , Relative Volume (over 3 month) > 3.0 all that yield to strong "Buy".
The target price will be at least +18%,

This is not a recommendation to "buy" or "sell", everyone should do according to his / her sole discretion .
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.